Influenza A Virus Neuraminidase antibody (AA 120-170)

Catalog No. ABIN5689891

The Rabbit Polyclonal anti-Influenza A Virus Neuraminidase antibody has been validated for ELISA. It is suitable to detect Influenza A Virus Neuraminidase in samples from Influenza A Virus H7N9.

Quick Overview for Influenza A Virus Neuraminidase antibody (AA 120-170) (ABIN5689891)

Target: Influenza A Virus Neuraminidase (NA)

Reactivity: Influenza A Virus H7N9

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Influenza A Virus Neuraminidase antibody is un-conjugated

Application: ELISA

Product Details anti-Influenza A Virus Neuraminidase Antibody

Binding Specificity: AA 120-170

Specificity: Virus

Purification: Avian Influenza A H7N9 Neuraminidase antibody is affinity chromatography purified via peptide column.

Immunogen: Avian Influenza A H7N9 Neuraminidase antibody was raised against a synthetic peptide corresponding to 17 amino acids near the amino terminus of the H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] Neuraminidase protein.

The immunogen is located within amino acids 120 - 170 of Avian Influenza A H7N9 Neuraminidase.

Isotype: IgG

Application Details

Application Notes: Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 μ,g/mL.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: Avian Influenza A H7N9 Neuraminidase Antibody is supplied in PBS containing 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Avian Influenza A H7N9 Neuraminidase antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Target Details for Influenza A Virus Neuraminidase

Target: Influenza A Virus Neuraminidase (NA)

Alternative Name: Influenza A Virus Neuraminidase

Target Type: Influenza Protein

Background: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals, however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

UniProt: R4NFR6